Company Filing History:
Years Active: 2020-2021
Title: Fern R McSorley: Innovator in Microbial Biotechnology
Introduction
Fern R McSorley is a notable inventor based in Emeryville, CA (US). He has made significant contributions to the field of microbial biotechnology, particularly in the production of nepetalactone, a compound known for its effects on cats. With a total of 2 patents, McSorley has been at the forefront of innovative research and development.
Latest Patents
His latest patents focus on nepetalactol oxidoreductases, nepetalactol synthases, and microbes capable of producing nepetalactone. The present disclosure provides isolated nepetalactone oxidoreductase polypeptides (NORs), nepetalactol synthases (NEPSs), and related polynucleotides, engineered host cells, and cultures. Additionally, it outlines methods for producing NORs and NEPSs, and for using them to produce nepetalactol, nepetalactone, and dihydronepetalactone. Furthermore, the disclosure includes methods for engineering microbial cells to produce nepetalactone from fermentation substrates such as glucose.
Career Highlights
Fern R McSorley is currently associated with Zymergen Inc., where he continues to push the boundaries of microbial engineering. His work has implications not only for the pet industry but also for broader applications in biotechnology.
Collaborations
He collaborates with talented individuals such as Grayson Wawrzyn and Christine Roche, who contribute to the innovative environment at Zymergen Inc. Their combined expertise fosters a culture of creativity and advancement in their projects.
Conclusion
Fern R McSorley exemplifies the spirit of innovation in biotechnology through his patents and collaborative efforts. His work in producing nepetalactone showcases the potential of microbial engineering in various applications.